Cargando…
RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer
Raf kinase inhibitor protein (RKIP), an important modulator of intracellular signalling pathways, is commonly downregulated in multiple cancers. This reduction, or loss of expression, is correlated not only with the presence of metastasis, contributing to RKIP’s classification as a metastasis suppre...
Autores principales: | Gabriela-Freitas, Maria, Pinheiro, Joana, Raquel-Cunha, Ana, Cardoso-Carneiro, Diana, Martinho, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995551/ https://www.ncbi.nlm.nih.gov/pubmed/31766768 http://dx.doi.org/10.3390/biom9120769 |
Ejemplares similares
-
Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling
por: Raquel-Cunha, Ana, et al.
Publicado: (2019) -
RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity
por: Touboul, Roni, et al.
Publicado: (2021) -
Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
por: Martinho, Olga, et al.
Publicado: (2012) -
Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis
por: Campanella, Nathália Cristina, et al.
Publicado: (2023) -
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
por: Papale, Massimo, et al.
Publicado: (2017)